Cyclooxygenase Inhibitors
"Cyclooxygenase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.
Descriptor ID |
D016861
|
MeSH Number(s) |
D27.505.519.389.310 D27.505.696.663.850.014.040.500.500 D27.505.954.158.030.500 D27.505.954.329.030.500
|
Concept/Terms |
Cyclooxygenase Inhibitors- Cyclooxygenase Inhibitors
- Inhibitors, Cyclo-Oxygenase
- Inhibitors, Cyclo Oxygenase
- Inhibitors, Cyclooxygenase
- Prostaglandin Synthesis Antagonists
- Antagonists, Prostaglandin Synthesis
- Inhibitors, Prostaglandin-Endoperoxide Synthase
- Inhibitors, Prostaglandin Endoperoxide Synthase
- Prostaglandin Endoperoxide Synthase Inhibitors
- Prostaglandin Synthase Inhibitors
- Cyclo-Oxygenase Inhibitors
- Cyclo Oxygenase Inhibitors
- Inhibitors, Prostaglandin Synthase
|
Below are MeSH descriptors whose meaning is more general than "Cyclooxygenase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Cyclooxygenase Inhibitors".
This graph shows the total number of publications written about "Cyclooxygenase Inhibitors" by people in this website by year, and whether "Cyclooxygenase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 3 | 3 |
1995 | 1 | 1 | 2 |
1996 | 0 | 3 | 3 |
1998 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2000 | 0 | 1 | 1 |
2002 | 1 | 2 | 3 |
2003 | 1 | 2 | 3 |
2004 | 0 | 1 | 1 |
2005 | 1 | 2 | 3 |
2006 | 0 | 1 | 1 |
2008 | 2 | 0 | 2 |
2010 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2018 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclooxygenase Inhibitors" by people in Profiles.
-
PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age. J Pediatr. 2019 02; 205:41-48.e6.
-
Abdominal skeletal muscle activity precedes spontaneous menstrual cramping pain in primary dysmenorrhea. Am J Obstet Gynecol. 2018 07; 219(1):91.e1-91.e7.
-
Epithelium-dependent modulation of responsiveness of airways from caveolin-1 knockout mice is mediated through cyclooxygenase-2 and 5-lipoxygenase. Br J Pharmacol. 2012 Oct; 167(3):548-60.
-
Intra-renal oxygenation in rat kidneys during water loading: effects of cyclooxygenase (COX) inhibition and nitric oxide (NO) donation. J Magn Reson Imaging. 2010 Aug; 32(2):383-7.
-
Aspirin, NSAIDs, and cardiovascular risk: is there a link? Am J Med. 2008 Nov; 121(11):e9.
-
Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial. J Pediatr. 2008 Aug; 153(2):183-9.
-
Ovulation-selective genes: the generation and characterization of an ovulatory-selective cDNA library. J Endocrinol. 2006 Mar; 188(3):531-48.
-
Other compounds and targets in non-small cell lung cancer. Semin Oncol. 2005 Dec; 32(6 Suppl 10):S30-6.
-
Perioperative rofecoxib plus local anesthetic field block diminishes pain and recovery time after outpatient inguinal hernia repair. Anesth Analg. 2005 Jul; 101(1):83-9, table of contents.
-
Spectral markers in preneoplastic intestinal mucosa: an accurate predictor of tumor risk in the MIN mouse. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1639-45.